CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-20). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 870 · Search date 2026-07-20 · Methodology v0.6

Acer tegmentosum extract,
does it really help with Relief of hangover and improvement of alcohol-related liver injury, fatty liver, and liver enzymes?

30-Second Summary
D
Evidence Grade D · 23 · Safety unknown
Mouse and cell studies suggest hepatoprotection, but isolated human effects on hangover or alcohol-related liver disease are unproven
What the
research shows
Acer tegmentosum extract is rated D for relieving hangover and improving alcohol-related liver injury, fatty liver, or liver enzymes. Direct positive evidence is mainly preclinical, measuring transaminases, fat accumulation, oxidative pathways, and autophagy in alcohol- or carbon-tetrachloride-injured mice and HepG2 cells. A 25-person randomized crossover hangover study included Acer tegmentosum at 0.1% as a minor ingredient, but the beverages also contained Hovenia dulcis, Pueraria lobata or glutathione yeast, Alnus japonica, fermented rice embryo, albumin, and other ingredients, so the isolated effect cannot be determined. No controlled single-ingredient human trial was identified for alcohol-related fatty liver or sustained liver-enzyme improvement, supporting D for preclinical-only evidence.
What the
ads claim
Marketing translates lower transaminases in mice and antioxidant signals in cells into liver detoxification and fatty-liver treatment in humans, then attributes a combination beverage result to Acer tegmentosum alone. Hangover symptom relief and treatment of steatosis, hepatitis, or fibrosis are distinct clinical claims.
*

Useful facts when choosing a product

  • Acer tegmentosum is a maple-family tree whose stems, twigs, and bark have traditional East Asian uses; extraction solvent, plant part, and marker compounds differ across studies.
  • Recognition as a food or functional ingredient indicates evidence and specifications for defined manufacturing conditions, not proven clinical efficacy for every commercial product.
  • Hangover beverages commonly combine Hovenia, kudzu, yeast, alder, vitamins, and other ingredients, so even a product effect cannot identify the contribution of Acer tegmentosum.
  • Preclinical repeated-dose studies provide some reassurance, but human long-term use, use in liver disease, medicine interactions, and product-specific purity and standardization remain inadequately characterized.
Gap Measurement · Verdict 870 · D 23
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Lee and colleagues administered HIMH0021, a flavonoid from Acer tegmentosum extract, in a chronic-plus-binge mouse model and assessed ALT, AST, hepatic fat, CYP2E1, inflammation, and AMPK-related markers. Park and colleagues applied an Acer tegmentosum water extract to mice injured by alcohol or carbon tetrachloride and to HepG2 cells exposed to hydrogen peroxide or alcohol, measuring transaminases, triglycerides, malondialdehyde, Nrf2 and HO-1, and autophagy. In the human study by Lee and colleagues, 25 adults with prior hangover experience crossed over between placebo and two combination beverages. Acer tegmentosum was a 0.1% minor ingredient in both test beverages, which also shared Hovenia dulcis, Alnus japonica, fermented rice embryo, albumin, vitamin C, and other ingredients and differed in Pueraria lobata or glutathione yeast. No isolated effect can be estimated.

02

Why this is classified as D (23)

Positive signals for enzymes, fat accumulation, and oxidative pathways come from alcohol-injured mice and HepG2 cells. There is no human efficacy evidence for Acer tegmentosum itself: the 25-person publication tested a Hovenia dulcis-led multi-ingredient beverage in which Acer tegmentosum was only a shared 0.1% minor ingredient. With no single-ingredient human trial for hangover, alcoholic fatty liver, or sustained enzymes, preclinical-only evidence gives D with 23 points.

Counterpoint. Persistent elevation of AST or ALT or fatty liver calls for alcohol reduction or abstinence, weight and metabolic-risk management, and diagnosis of the cause. A hangover product does not prevent alcohol harm or create a safer drinking allowance.

Rejudgment record. New verdict — Accepted positive Acer tegmentosum liver-enzyme, steatosis, and oxidative-marker signals in alcohol-injured mice and HepG2 cells, but treated the 25-person Hovenia-led combination beverage as no human efficacy evidence for Acer tegmentosum because it was only a shared 0.1% minor ingredient; no single-ingredient human outcome exists for hangover, alcoholic fatty liver, or sustained liver enzymes

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Relief of hangover symptomsDAcer tegmentosum itself has only preclinical evidence. The 25-person study tested a Hovenia-led multi-ingredient beverage in which it was only a shared 0.1% minor ingredient, so no human effect can be attributed to it.
Improvement of alcohol-related liver injury and fatty liverDPositive findings are confined to mice and HepG2 cells, with no clinical outcomes in patients.
Improvement of liver enzymes such as AST and ALTDMouse surrogate markers improved, but no single-ingredient trial verified sustained liver-enzyme improvement in humans.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Lee Y et al. 2017Chronic-plus-binge mouse study and hepatocyte mechanism experiments using a constituent isolated from Acer tegmentosum0Korea Forest Service forest-science research supportALT, AST, hepatic fat, inflammation, CYP2E1, and AMPK signalingHIMH0021 reduced transaminases, fat accumulation, and inflammation in alcohol-exposed mice.Direct-ingredient preclinical signal
Park HS et al. 2019Alcohol- and carbon-tetrachloride-injured mouse and HepG2 cell experiments0Academic and functional-ingredient development contextTransaminases, triglycerides, malondialdehyde, Nrf2 and HO-1, and autophagyThe water extract improved markers of mouse liver injury and cellular oxidative injury.Corroborating preclinical evidence
Lee KW et al. 2024Randomized double-blind placebo-controlled crossover hangover trial25Korean Ministry of Food and Drug Safety support; multiple Kwangdong Pharmaceutical employee authorsBlood alcohol, acetaldehyde, and Acute Hangover ScaleCombination beverages improved selected early alcohol and hangover measures, but Acer tegmentosum was a 0.1% minor ingredient among many, preventing isolation of its effect.Human evidence for a Hovenia-led combination, not human efficacy evidence for Acer tegmentosum
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-07-20).

Lee Y, Kwon DJ, Kim YH, et al. HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice. PLoS One. 2017;12(11):e0185134. PMID: 29091708. PMCID: PMC5665428. DOI: 10.1371/journal.pone.0185134.
checked
Park HS, Jo E, Han JH, et al. Hepatoprotective effects of an Acer tegmentosum Maxim extract through antioxidant activity and the regulation of autophagy. J Ethnopharmacol. 2019;239:111912. PMID: 31029758. DOI: 10.1016/j.jep.2019.111912.
checked
Lee KW, Xu G, Paik DH, et al. Clinical Evaluation of Hovenia dulcis Extract Combinations for Effective Hangover Relief in Humans. Foods. 2024;13(24):4021. PMID: 39766963. PMCID: PMC11675335. DOI: 10.3390/foods13244021.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-20 · Corrections: none

Cite this verdict

Acer tegmentosum extract x hangover relief and alcohol-related liver improvement Evidence Grade D card
[Chamgap] Acer tegmentosum extract x hangover relief and alcohol-related liver improvement — Evidence Grade D·23. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/liver/acer-tegmentosum-hangover-alcoholic-liver/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.